Literature DB >> 19871229

ADSORPTION OF INFLUENZA HEMAGGLUTININS AND VIRUS BY RED BLOOD CELLS.

G K Hirst1.   

Abstract

A number of experiments were performed on the adsorption of influenza hemagglutinins on chicken red blood cells, from which the following conclusions were drawn:- 1. When chicken red blood cells and preparations of influenza viruses were mixed together, the influenza hemagglutinins present were rapidly adsorbed onto the cells. After varying lengths of time, dependent on the conditions of the experiment, the adsorbed hemagglutinins began to elute from the cells. With the Lee strain at 23 degrees C. and the PR8 strain at 37 degrees C. almost all of the adsorbed agglutinin was released in 4 to 6 hours. 2. When the number of red cells used for adsorption was increased, the speed and degree of adsorption of the hemagglutinins increased. The time of maximum adsorption of hemagglutinins was the same, regardiess of red cell concentration, and with the larger amounts of red cells the speed and degree of elution was decreased. 3. When adsorption of PR8 virus agglutinins was carried out at 4 degrees C. the adsorption was rapid and nearly complete. When the reaction was carried out at higher temperatures (27 degrees and 37 degrees C.), the adsorption was equally rapid but was progressively less complete with rise in temperature. At 4 degrees C. the maximum adsorption was not reached for 5 hours; at 27 degrees C. it was reached in 25 minutes; and at 37 degrees C. the greatest degree of adsorption was attained between 3 and 5 minutes. The amount of elution observed at 4 degrees C. at 18 hours was negligible, but the degree of elution increased with temperature so that at 37 degrees C. almost all of the adsorbed agglutinin was released in 6 hours' time. 4. Red cells which had adsorbed and then fully eluted the agglutinin were not capable of adsorbing a detectable amount of fresh agglutinin. In addition, such cells would no longer agglutinate even though exposed to fresh virus suspensions. 5. The hemagglutinin of influenza B virus was capable of being adsorbed on and eluted from several successive lots of chicken red cells without appreciable loss of agglutinating activity. 6. The hemagglutinins of the PR8 and Lee strains were rapidly inactivated at 60 degrees C. The presence of active virus was not necessary for the occurrence of the adsorption-elution reaction on chicken red cells. 7. The activity of the portion of the red cells responsible for the adsorption of the hemagglutinins persisted, though in reduced amount, even after heating for 5 minutes at 100 degrees C. Hemagglutinins were adsorbed and eluted from red cell stroma. 8. The infective agent in influenza virus suspensions was adsorbed by chicken red cells simultaneously with the adsorption of hemagglutinins. 95 per cent of the infective agent was removed from suspension by the red cells after contact for 15 minutes. From then on the infective agent was gradually released from the red cells. After 4 hours the 50 per cent mortality titer of the supernatant fluid was as high as at the beginning of the experiment.

Entities:  

Year:  1942        PMID: 19871229      PMCID: PMC2135226          DOI: 10.1084/jem.76.2.195

Source DB:  PubMed          Journal:  J Exp Med        ISSN: 0022-1007            Impact factor:   14.307


  5 in total

1.  THE AGGLUTINATION OF RED CELLS BY ALLANTOIC FLUID OF CHICK EMBRYOS INFECTED WITH INFLUENZA VIRUS.

Authors:  G K Hirst
Journal:  Science       Date:  1941-07-04       Impact factor: 47.728

2.  TRANSMISSION OF INFLUENZA BY A FILTERABLE VIRUS.

Authors:  T Francis
Journal:  Science       Date:  1934-11-16       Impact factor: 47.728

3.  A NEW TYPE OF VIRUS FROM EPIDEMIC INFLUENZA.

Authors:  T Francis
Journal:  Science       Date:  1940-11-01       Impact factor: 47.728

4.  THE QUANTITATIVE DETERMINATION OF INFLUENZA VIRUS AND ANTIBODIES BY MEANS OF RED CELL AGGLUTINATION.

Authors:  G K Hirst
Journal:  J Exp Med       Date:  1942-01-01       Impact factor: 14.307

5.  ANTIBODY RESPONSE OF HUMAN BEINGS FOLLOWING VACCINATION WITH INFLUENZA VIRUSES.

Authors:  G K Hirst; E R Rickard; L Whitman; F L Horsfall
Journal:  J Exp Med       Date:  1942-05-01       Impact factor: 14.307

  5 in total
  92 in total

1.  [Fucose containing mucins predominantly of entodermal origin with blood group and other biological characteristics].

Authors:  G F SPRINGER
Journal:  Klin Wochenschr       Date:  1955-04-15

2.  [Myxovirus hemaggIutination tests with various erythrocyte types. Comparative quantitative studies under various conditions].

Authors:  B SCHMIDT; K GROSSGEBAUER
Journal:  Z Hyg Infektionskr       Date:  1959

3.  [Homologous interference by heat-inactivated influenza-B-virus absorbed on erythrocytes].

Authors:  H MOOSER; J LINDENMANN
Journal:  Experientia       Date:  1957-04-15

4.  A factor in bovine amniotic fluid inhibiting influenza virus hemagglutination.

Authors:  E LYCKE
Journal:  Arch Gesamte Virusforsch       Date:  1954

5.  [Studies on the effect of blood corpuscles on hemagglutination test with influenza and mumps virus].

Authors:  G BRAND; H LIPPELT; F MULLER
Journal:  Z Hyg Infektionskr       Date:  1954

6.  Recent work on the intrinsic qualities of influenza virus; somatic and genetic aspects.

Authors:  M BURNET
Journal:  Bull World Health Organ       Date:  1953       Impact factor: 9.408

7.  [Laboratory methods applied to the study of the influenza virus].

Authors:  P LEPINE
Journal:  Bull World Health Organ       Date:  1953       Impact factor: 9.408

8.  The question of the presence of influenza virus in the faeces of mice after infection and feeding with the virus.

Authors:  G J SCHIPPER
Journal:  Antonie Van Leeuwenhoek       Date:  1948       Impact factor: 2.271

9.  On the hemagglutinins of beans and influenza virus.

Authors:  J BOURDILLON
Journal:  Experientia       Date:  1949-03-15

10.  Studies on host-virus interactions in the chick embryo-influenza virus system. IV. The role of inhibitors of hemagglutination in the evaluation of viral multiplication.

Authors:  O C LIU; W HENLE
Journal:  J Exp Med       Date:  1951-10       Impact factor: 14.307

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.